Development of inclusion complex based on cyclodextrin and oxazolidine derivative
Development of inclusion complex based on cyclodextrin and oxazolidine derivative
About this item
Full title
Author / Creator
Publisher
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
Journal title
Language
English
Formats
Publication information
Publisher
Universidade de São Paulo, Faculdade de Ciências Farmacêuticas
Subjects
More information
Scope and Contents
Contents
Abstract Oxazolidine derivatives (OxD) have been described as third-line antibiotics and antitumoral agents. The inclusion complexes based on cyclodextrin could improve the solubility and bioavailability of these compounds. A novel synthetic OxD was used, and its inclusion complexes were based on 2-hydroxy-beta-cyclodextrin (2-HPβCD). We conducted...
Alternative Titles
Full title
Development of inclusion complex based on cyclodextrin and oxazolidine derivative
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_837bbb78eb474b28bcac1c86c2e747b7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_837bbb78eb474b28bcac1c86c2e747b7
Other Identifiers
ISSN
2175-9790
E-ISSN
2175-9790
DOI
10.1590/s2175-97902023e22009
